Chenting Zhang Selected Research

Mucin-1 (CA 15-3 Antigen)

7/2017	Sputum mucin 1 is increased during the acute phase of chronic obstructive pulmonary disease exacerbation.
1/2014	Tanshinone IIA inhibits lipopolysaccharide-induced MUC1 overexpression in alveolar epithelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chenting Zhang Research Topics

Disease

9	Chronic Obstructive Pulmonary Disease (COPD) 11/2020 - 01/2016
6	Hypoxia (Hypoxemia) 01/2023 - 01/2018
5	Pulmonary Hypertension 01/2022 - 01/2018
3	Neoplasms (Cancer) 01/2019 - 08/2013
3	Inflammation (Inflammations) 11/2018 - 11/2014
2	Right Ventricular Hypertrophy 10/2022 - 01/2021
2	Lung Neoplasms (Lung Cancer) 10/2018 - 08/2013
2	Pneumonia (Pneumonitis) 07/2017 - 01/2014
1	Vascular Remodeling 10/2022
1	Pulmonary Veno-Occlusive Disease (Veno Occlusive Disease, Pulmonary) 01/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Familial Primary Pulmonary Hypertension 01/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Emphysema 11/2018
1	Airway Remodeling 11/2018
1	Neoplasm Metastasis (Metastasis) 10/2018
1	Atrophy 01/2017
1	Pulmonary Arterial Hypertension 03/2016
1	Lung Diseases (Lung Disease) 01/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2013

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2016
4	SmokeIBA 05/2019 - 01/2017
3	LipopolysaccharidesIBA 11/2018 - 11/2014
2	Semaxinib (SU5416)IBA 01/2023 - 01/2022
2	CalciumIBA 01/2021 - 10/2018
2	3' Untranslated Regions (3' UTR)IBA 11/2020 - 03/2016
2	cholesteryl-6-pyrenylhexanoate (ChPH)IBA 01/2020 - 01/2018
2	Long Noncoding RNAIBA 05/2019 - 01/2018
2	CytokinesIBA 11/2018 - 07/2017
2	tanshinoneIBA 01/2018 - 01/2014
2	Mucin-1 (CA 15-3 Antigen)IBA 07/2017 - 01/2014
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2022
1	salicylhydroxamic acid (SHAM)IBA 10/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 10/2022
1	Therapeutic UsesIBA 01/2022
1	PT2385IBA 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021
1	indium-bleomycinIBA 01/2021
1	Growth Differentiation Factor 2IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2021
1	Protein CIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	CollagenIBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	cadherin 5IBA 01/2020
1	Platelet Endothelial Cell Adhesion Molecule-1IBA 01/2020
1	VimentinIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	Transient Receptor Potential ChannelsIBA 01/2019
1	MonocrotalineIBA 01/2019
1	Nicotine FDA Link 10/2018
1	tanshinone II A sodium sulfonateIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 07/2017
1	Serum Response FactorIBA 01/2017
1	human ABRA proteinIBA 01/2017
1	5' Untranslated Regions (5' UTR)IBA 03/2016
1	Messenger RNA (mRNA)IBA 03/2016
1	Environmental BiomarkersIBA 01/2016
1	Bone Morphogenetic Protein 4IBA 11/2014
1	Chemotactic FactorsIBA 01/2014
1	Ethanol (Ethyl Alcohol)IBA 08/2013
1	Antineoplastic Agents (Antineoplastics)IBA 08/2013
1	4-toluenesulfonamideIBA 08/2013

Therapy/Procedure

1	Ligation 10/2022
1	Transplantation 01/2020
1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 08/2013
1	Radiotherapy 08/2013